Mediastinal germ cell tumour with an uncommon micropapillary architecture on histology

Our plain-English summary of Mediastinal germ cell tumour with an uncommon micropapillary architecture on histology, by A. von Rohr, A. Zimmermann, K.W. Brunner, et al (Annals of Oncology, 1991).

The study

• Authors: A. von Rohr, A. Zimmermann, K.W. Brunner, M.F. Fex
• Journal: Annals of Oncology
• Published: 1991;2(10):771-2
• Type of article: Case report, Letter
• Read it: PubMed · Publisher

In plain English

This case report described one patient: a 24-year-old previously healthy man in Switzerland with a bulky tumour in the anterior mediastinum, the area in the chest between the lungs. The article does not mention asbestos or any other exposure. Under the microscope the tumour biopsies were at first thought to suggest a mesothelioma. Special staining then showed strong alpha-foetoprotein (AFP) in some tumour cells, cytokeratin in most cells, and carcinoembryonic antigen in only a few. Vimentin and human choriogonadotropin were negative. His blood AFP was 16,000 U/ml (normal under 10). The final diagnosis was a mediastinal non-seminomatous germ cell tumour with an unusual micropapillary pattern. He received seven cycles of cisplatin, etoposide, bleomycin and ifosfamide. The fluid around his lungs had cleared after two cycles. After four cycles his tumour markers were normal and a small mass remained on CT. At two years of follow-up he had returned to full work. The authors wrote that, to their knowledge, this tumour type had not been described before. They concluded that it should be distinguished from mesothelioma because treatment would differ markedly.

We wrote this plain-English summary from the full article with the help of AI, and a second AI model checked each sentence against the article. It is not the authors' wording; the abstract and the article are their own account.

What the study did and found

• Design: case report (letter describing a single patient)
• Who was studied: One 24-year-old previously healthy man with a bulky anterior mediastinal tumour, treated at Bern, Switzerland
• Exposure: Not reported; the article does not mention asbestos or any other exposure
• Main results:
  • In this patient, the tumour biopsies were initially thought to suggest a mesothelioma
  • On immunohistochemistry, a subpopulation of the patient's tumour cells strongly expressed AFP
  • The patient's serum alpha-foetoprotein was 16,000 U/ml (normal less than 10)
  • The patient was diagnosed with a mediastinal non-seminomatous germ cell tumour with an unusual micropapillary pattern
  • After two of seven chemotherapy cycles, the patient's pleural effusions had completely disappeared
  • After four cycles, the patient had a small residual mediastinal mass on CT
  • At two years of follow-up, the patient had resumed full professional activity
• The authors' conclusion: The authors stated that, to their knowledge, mediastinal micropapillary NSGCT had not been described before. They concluded that it is important to tell this tumour apart from mesothelioma because treatment approaches differ markedly.

Topics

Medical terms in this study, explained in our Lexicon: Micropapillary, Histology.

Related studies

• RNA-binding protein LIN28 is a marker for primary extragonadal germ cell tumors: an immunohistochemical study of 131 cases — D. Cao, A. Liu, et al. (2011)
• Nuclear Brachyury Expression Is Consistent in Chordoma, Common in Germ Cell Tumors and Small Cell Carcinomas, and Rare in Other Carcinomas and Sarcomas: An Immunohistochemical Study of 5229 Cases — M. Miettinen, Z. Wang, et al. (2015)
• Minimally invasive, ionizing-free, and ultrasound-guided technique to biopsy anterior mediastinal masses: first 60 cases — B. Lorenzati, R. Cristofori, et al. (2018)
• Mediastinal and pleuropulmonary myeloid sarcoma with HBME1 and podoplanin expression. A diagnostic pitfall — D. Suárez-Vilela, F.M. Izquierdo (2020)
• Surgery for invasive primary mediastinal tumors — E.A. Bacha, A.R. Chapelier, et al. (1998)
• Mesothelioma and anti-Ma paraneoplastic syndrome; heterogeneity in immunogenic tumours increases — H.A. Archer, A. Panopoulou, et al. (2014)

Browse more research in Annals of Oncology, or return to medical research.